Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Iopamidol
Drug ID BADD_D01181
Description Iopamidol is a contrast agent developed by Bracco with nonionic, low-osmolar properties.
Indications and Usage
Marketing Status Prescription; Discontinued
ATC Code V08AB04
DrugBank ID DB08947
KEGG ID D01797
MeSH ID D007479
PubChem ID 65492
TTD Drug ID D0O2HQ
NDC Product Code 57876-222; 68225-100; 0270-1314; 0270-1317; 0270-1316; 68225-076; 0270-1412; 0270-1315; 68225-077; 68225-078; 62331-006; 0270-1411
Synonyms Iopamidol | Jopamidol | Gastromiro | Iopamidol, (+-)-Isomer | Iopamidol, (R)-Isomer | Iopamidol, Sodium Salt, (S)-Isomer | Iopamiro | Isovue 370 | Niopam | Solutrast | Solutrast 370 | Solutrast Gastro | SQ 13,396 | B-15,000 | B 15,000 | B15,000 | B-15000 | B 15000 | B15000 | Isovue
Chemical Information
Molecular Formula C17H22I3N3O8
CAS Registry Number 60166-93-0
SMILES CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Agitation17.02.05.012; 19.06.02.001--
Amnesia17.03.02.001; 19.20.01.001--
Anaphylactic shock10.01.07.002; 24.06.02.004--Not Available
Anaphylactoid reaction10.01.07.003; 24.06.03.007--Not Available
Angina pectoris02.02.02.002; 24.04.04.002--
Anuria20.01.03.002--Not Available
Anxiety19.06.02.002--
Aortic injury12.01.11.005; 24.11.02.001--
Aphasia17.02.03.001; 19.21.01.001--
Apnoea22.02.01.001--
Areflexia17.02.01.001--Not Available
Arrhythmia02.03.02.001--Not Available
Arterial spasm24.04.02.011--Not Available
Arterial thrombosis24.01.01.002--Not Available
Aspiration pleural cavity13.19.03.002--Not Available
Asterixis09.01.03.004; 17.01.06.001--Not Available
Asthenia08.01.01.001--Not Available
Asthma10.01.03.010; 22.03.01.002--Not Available
Ataxia08.01.02.004; 17.02.02.001--
Back pain15.03.04.005--
Blindness06.02.02.001; 17.17.01.003--Not Available
Blindness cortical06.02.02.004; 17.17.01.017--Not Available
Blindness transient06.02.02.002; 17.17.01.004--Not Available
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Bronchospasm10.01.03.012; 22.03.01.004--
Burning sensation08.01.09.029; 17.02.06.001--Not Available
Cardiac arrest02.03.04.001--
Cardiac failure02.05.01.001--
The 1th Page    1 2 3 4 5    Next   Last    Total 7 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene